Funds holding Lyell Immunopharma Inc
ISIN US55083R2031 · United States
- Fund holders
- 41
- Of which ETFs
- 13 28 other funds
- Value held
- 24.9M $
- Share of capital
- 4.8 % of 24.5M shares on Aug 3, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 537,261 | 10.8M $ | 0.00 % | 2.19 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 162,212 | 3.3M $ | 0.00 % | 0.66 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 76,142 | 1.8M $ | 0.00 % | 0.31 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 68,538 | 1.6M $ | 0.01 % | 0.28 % | as of Feb 28, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 54,413 | 1.1M $ | 0.01 % | 0.22 % | as of Mar 31, 2026 ↗ |
| Invesco Dorsey Wright SmallCap Momentum ETF Invesco Exchange-Traded Fund Trust II | 44,564 | 1.1M $ | 0.28 % | 0.18 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 25,830 | 619.9K $ | 0.00 % | 0.11 % | as of Feb 28, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 23,103 | 554.5K $ | 0.00 % | 0.09 % | as of Feb 28, 2026 ↗ |
| SIMT Tax-Managed Small/Mid Cap Fund SEI INSTITUTIONAL MANAGED TRUST | 21,220 | 425.7K $ | 0.06 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 20,420 | 490.1K $ | 0.00 % | 0.08 % | as of Feb 28, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 18,000 | 361.1K $ | 0.29 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 12,766 | 251.9K $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 12,413 | 297.9K $ | 0.01 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 11,621 | 278.9K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 10,025 | 197.8K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 9,320 | 187K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 9,238 | 185.3K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 9,101 | 218.4K $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 8,842 | 174.5K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 8,434 | 166.4K $ | 0.01 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 8,143 | 160.7K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 7,428 | 146.6K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 6,557 | 131.5K $ | 0.01 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 4,972 | 98.1K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 2,211 | 44.4K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 2,161 | 42.6K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 1,418 | 28K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Dimensional US Core Equity Market ETF Dimensional ETF Trust | 1,396 | 27.5K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| U.S. CORE EQUITY 1 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 1,241 | 24.5K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 1,207 | 29K $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 979 | 23.5K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 827 | 16.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Hypatia Women CEO ETF Two Roads Shared Trust | 688 | 13.6K $ | 0.16 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 616 | 12.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Diversified Equity Master Portfolio Master Investment Portfolio | 558 | 11.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| U.S. Social Core Equity 2 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 498 | 9.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 409 | 8.1K $ | 0.00 % | as of Apr 30, 2026 ↗ | |
| Avantis U.S. Equity ETF American Century ETF Trust | 346 | 8.3K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 339 | 6.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 145 | 2.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 93 | 1.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.29 % | as of Mar 31, 2026 ↗ |
| Invesco Dorsey Wright SmallCap Momentum ETF Invesco Exchange-Traded Fund Trust II | 0.28 % | as of Feb 28, 2026 ↗ |
| Hypatia Women CEO ETF Two Roads Shared Trust | 0.16 % | as of Apr 30, 2026 ↗ |
| SIMT Tax-Managed Small/Mid Cap Fund SEI INSTITUTIONAL MANAGED TRUST | 0.06 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 0.04 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 0.03 % | as of Feb 28, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 0.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 0.01 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 0.01 % | as of Feb 28, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 0.01 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 41 | +8 | 1,185,695 | +13.7 % |
| 2026Q1 | 33 | +7 | 1,042,636 | +8.0 % |
| 2025Q4 | 26 | +4 | 965,259 | +27.6 % |
| 2025Q3 | 22 | 756,714 |
Institutional managers
69 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| ARCH Venture Management, LLC | 3,247,162 | 65.1M $ | as of Mar 31, 2026 |
| GSK plc | 1,512,659 | 30.3M $ | as of Mar 31, 2026 |
| Foresite Capital Management IV, LLC | 800,399 | 16.1M $ | as of Mar 31, 2026 |
| Orland Properties Ltd | 754,698 | 15.1M $ | as of Mar 31, 2026 |
| Almitas Capital LLC | 577,807 | 11.6M $ | as of Mar 31, 2026 |
| Foresite Capital Management V, LLC | 477,078 | 9.6M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 458,905 | 9.2M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 381,462 | 7.7M $ | as of Mar 31, 2026 |
| venBio Partners LLC | 337,697 | 6.8M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 310,198 | 6.2M $ | as of Mar 31, 2026 |
| Alphabet Inc. | 293,256 | 5.9M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 191,820 | 3.8M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 166,980 | 3.4M $ | as of Mar 31, 2026 |
| HSG Holding Ltd | 152,299 | 73.1K $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 148,516 | 3M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 116,411 | 2.3M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 114,491 | 2.3M $ | as of Mar 31, 2026 |
| Velan Capital Investment Management LP | 102,000 | 2M $ | as of Mar 31, 2026 |
| MIC Capital Management UK LLP | 87,028 | 1.7M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 85,971 | 1.7M $ | as of Mar 31, 2026 |
| Opaleye Management Inc. | 79,097 | 1.6M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 72,522 | 1.5M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 63,893 | 1.3M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 56,151 | 1.1M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 55,110 | 1.1M $ | as of Mar 31, 2026 |
Declared shareholders of Lyell Immunopharma Inc
5 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| ARCH Venture Fund IX, L.P. and 13 others | 13.90 % | 3,247,162 | as of Mar 31, 2026 · SCHEDULE 13G |
| Innovative Cellular Therapeutics Holdings Limited | 12.30 % | 3,000,000 | as of May 18, 2026 · SCHEDULE 13G |
| EULER FUND, L.P. and 2 others | 6.71 % | 1,426,528 | as of Mar 6, 2026 · SCHEDULE 13G |
| Explore Investments LLC and 1 other | 6.60 % | 1,529,054 | as of Mar 31, 2026 · SCHEDULE 13G |
| MWG Caph Ltd and 1 other | 4.30 % | 1,008,116 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Lyell Immunopharma Inc". https://titelia.com/en/stocks/lyell-immunopharma-inc-US55083R2031